Use of serum long non-coding RNA expression panel as a marker for diabetic retinopathy
Further longitudinal studies are necessary to validate the model's capability to predict retinopathy in diabetic patients not yet diagnosed with DR. Nevertheless, our findings indicate that this lncRNA panel may offer a viable option for a simple, accessible, and convenient blood-based screening test for DR.
Authors
- Biao Feng (ORCID: https://orcid.org/0000-0001-7523-5478)
- John R. Gonder
- Subrata Chakrabarti (ORCID: https://orcid.org/0000-0002-0208-1401)
- Shali Chen
- Tom Sheidow (ORCID: https://orcid.org/0000-0001-6370-1857)
- Selina Liu (ORCID: https://orcid.org/0000-0002-0261-0385)
- Eric Wang (ORCID: https://orcid.org/0000-0001-5140-5567)
- Arshad Ali (ORCID: https://orcid.org/0000-0003-1842-8040)
- Phil Hooper
Institutions
- Western University (CA)
- London Health Sciences Centre (CA)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-04-09
- DOI
- https://doi.org/10.3389/fcvm.2025.1523997
- Citations
- 1
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.94